Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
March 18, 2022 at 03:46 pm
Share
Arich Enterprise Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 999.65 million compared to TWD 1,403.11 million a year ago. Revenue was TWD 945.66 million compared to TWD 1,251.4 million a year ago.
Net income was TWD 55.31 million compared to TWD 47.25 million a year ago. Basic earnings per share from continuing operations was TWD 0.74 compared to TWD 0.72 a year ago. Diluted earnings per share from continuing operations was TWD 0.74 compared to TWD 0.72 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
